世界の糖尿病薬物療法市場 2021：企業別、地域別、種類・用途別

• 英文タイトル：Global Diabetes Drug Therapy Market 2021 by Company, Regions, Type and Application, Forecast to 2026

• レポートコード：GIR-2104Z04317
• 出版社/出版日：GlobalInfoResearch / 2021年4月
※2025年版があります。お問い合わせください。
• レポート形態：英文、PDF、109ページ
• 納品方法：Eメール（納期：2~3日）
• 産業分類：医療・医薬品

• 販売価格（消費税別）

Single User	￥504,600 (USD3,480)	▷ お問い合わせ
Multi User	￥756,900 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,009,200 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

当調査資料では、糖尿病薬物療法のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。糖尿病薬物療法の種類別市場規模（経口、皮下、静脈内）、用途別市場規模（オンライン薬局、病院薬局、小売薬局）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。
・糖尿病薬物療法の市場概要
・企業情報（企業概要、製品概要、販売量、価格、売上）：Abbott Laboratories、Mannkind Corporation、Bristol Myers Squibb、Medtronic、AstraZeneca、Eli Lilly and Company、GlaxoSmithKline、Sanofi、Novo Nordisk、Novartis International AG
・企業別市場シェア
・地域別市場分析2016年-2026年
・種類別分析2016年-2026年：経口、皮下、静脈内
・用途別分析2016年-2026年：オンライン薬局、病院薬局、小売薬局
・糖尿病薬物療法の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ
・糖尿病薬物療法のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア
・糖尿病薬物療法のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア
・糖尿病薬物療法の南米市場規模2016年-2026年：ブラジル、アルゼンチン
・糖尿病薬物療法の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Diabetes Drug Therapy market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Diabetes Drug Therapy size is estimated to be USD 13360 million in 2025 from USD 9269.8 million in 2019, with a change XX% between 2019 and 2020. The global Diabetes Drug Therapy market size is expected to grow at a CAGR of 9.6% for the next five years.

Market segmentation
Diabetes Drug Therapy market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
Oral
Subcutaneous
Intravenous

Market segment by Application, can be divided into
Online Pharmacies
Hospital Pharmacies
Retail Pharmacies

Market segment by players, this report covers
Abbott Laboratories
Mannkind Corporation
Bristol Myers Squibb
Medtronic
AstraZeneca
Eli Lilly and Company
GlaxoSmithKline
Sanofi
Novo Nordisk
Novartis International AG

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

レポート目次

1 Market Overview
1.1 Product Overview and Scope of Diabetes Drug Therapy
1.2 Classification of Diabetes Drug Therapy by Type
1.2.1 Overview: Global Diabetes Drug Therapy Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Diabetes Drug Therapy Revenue Market Share by Type in 2020
1.2.3 Oral
1.2.4 Subcutaneous
1.2.5 Intravenous
1.3 Global Diabetes Drug Therapy Market by Application
1.3.1 Overview: Global Diabetes Drug Therapy Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Online Pharmacies
1.3.3 Hospital Pharmacies
1.3.4 Retail Pharmacies
1.4 Global Diabetes Drug Therapy Market Size & Forecast
1.5 Global Diabetes Drug Therapy Market Size and Forecast by Region
1.5.1 Global Diabetes Drug Therapy Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Diabetes Drug Therapy Market Size by Region, (2016-2021)
1.5.3 North America Diabetes Drug Therapy Market Size and Prospect (2016-2026)
1.5.4 Europe Diabetes Drug Therapy Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Diabetes Drug Therapy Market Size and Prospect (2016-2026)
1.5.6 South America Diabetes Drug Therapy Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Diabetes Drug Therapy Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Diabetes Drug Therapy Market Drivers
1.6.2 Diabetes Drug Therapy Market Restraints
1.6.3 Diabetes Drug Therapy Trends Analysis
2 Company Profiles
2.1 Abbott Laboratories
2.1.1 Abbott Laboratories Details
2.1.2 Abbott Laboratories Major Business
2.1.3 Abbott Laboratories Diabetes Drug Therapy Product and Solutions
2.1.4 Abbott Laboratories Diabetes Drug Therapy Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Abbott Laboratories Recent Developments and Future Plans
2.2 Mannkind Corporation
2.2.1 Mannkind Corporation Details
2.2.2 Mannkind Corporation Major Business
2.2.3 Mannkind Corporation Diabetes Drug Therapy Product and Solutions
2.2.4 Mannkind Corporation Diabetes Drug Therapy Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Mannkind Corporation Recent Developments and Future Plans
2.3 Bristol Myers Squibb
2.3.1 Bristol Myers Squibb Details
2.3.2 Bristol Myers Squibb Major Business
2.3.3 Bristol Myers Squibb Diabetes Drug Therapy Product and Solutions
2.3.4 Bristol Myers Squibb Diabetes Drug Therapy Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Bristol Myers Squibb Recent Developments and Future Plans
2.4 Medtronic
2.4.1 Medtronic Details
2.4.2 Medtronic Major Business
2.4.3 Medtronic Diabetes Drug Therapy Product and Solutions
2.4.4 Medtronic Diabetes Drug Therapy Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Medtronic Recent Developments and Future Plans
2.5 AstraZeneca
2.5.1 AstraZeneca Details
2.5.2 AstraZeneca Major Business
2.5.3 AstraZeneca Diabetes Drug Therapy Product and Solutions
2.5.4 AstraZeneca Diabetes Drug Therapy Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 AstraZeneca Recent Developments and Future Plans
2.6 Eli Lilly and Company
2.6.1 Eli Lilly and Company Details
2.6.2 Eli Lilly and Company Major Business
2.6.3 Eli Lilly and Company Diabetes Drug Therapy Product and Solutions
2.6.4 Eli Lilly and Company Diabetes Drug Therapy Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Eli Lilly and Company Recent Developments and Future Plans
2.7 GlaxoSmithKline
2.7.1 GlaxoSmithKline Details
2.7.2 GlaxoSmithKline Major Business
2.7.3 GlaxoSmithKline Diabetes Drug Therapy Product and Solutions
2.7.4 GlaxoSmithKline Diabetes Drug Therapy Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 GlaxoSmithKline Recent Developments and Future Plans
2.8 Sanofi
2.8.1 Sanofi Details
2.8.2 Sanofi Major Business
2.8.3 Sanofi Diabetes Drug Therapy Product and Solutions
2.8.4 Sanofi Diabetes Drug Therapy Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 Sanofi Recent Developments and Future Plans
2.9 Novo Nordisk
2.9.1 Novo Nordisk Details
2.9.2 Novo Nordisk Major Business
2.9.3 Novo Nordisk Diabetes Drug Therapy Product and Solutions
2.9.4 Novo Nordisk Diabetes Drug Therapy Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 Novo Nordisk Recent Developments and Future Plans
2.10 Novartis International AG
2.10.1 Novartis International AG Details
2.10.2 Novartis International AG Major Business
2.10.3 Novartis International AG Diabetes Drug Therapy Product and Solutions
2.10.4 Novartis International AG Diabetes Drug Therapy Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 Novartis International AG Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Diabetes Drug Therapy Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 5 Diabetes Drug Therapy Players Market Share
3.2.2 Top 10 Diabetes Drug Therapy Players Market Share
3.2.3 Market Competition Trend
3.3 Diabetes Drug Therapy Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Diabetes Drug Therapy Revenue and Market Share by Type (2016-2021)
4.2 Global Diabetes Drug Therapy Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Diabetes Drug Therapy Revenue Market Share by Application (2016-2021)
5.2 Diabetes Drug Therapy Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Diabetes Drug Therapy Revenue by Type (2016-2026)
6.2 North America Diabetes Drug Therapy Revenue by Application (2016-2026)
6.3 North America Diabetes Drug Therapy Market Size by Country
6.3.1 North America Diabetes Drug Therapy Revenue by Country (2016-2026)
6.3.2 United States Diabetes Drug Therapy Market Size and Forecast (2016-2026)
6.3.3 Canada Diabetes Drug Therapy Market Size and Forecast (2016-2026)
6.3.4 Mexico Diabetes Drug Therapy Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Diabetes Drug Therapy Revenue by Type (2016-2026)
7.2 Europe Diabetes Drug Therapy Revenue by Application (2016-2026)
7.3 Europe Diabetes Drug Therapy Market Size by Country
7.3.1 Europe Diabetes Drug Therapy Revenue by Country (2016-2026)
7.3.2 Germany Diabetes Drug Therapy Market Size and Forecast (2016-2026)
7.3.3 France Diabetes Drug Therapy Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Diabetes Drug Therapy Market Size and Forecast (2016-2026)
7.3.5 Russia Diabetes Drug Therapy Market Size and Forecast (2016-2026)
7.3.6 Italy Diabetes Drug Therapy Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Diabetes Drug Therapy Revenue by Type (2016-2026)
8.2 Asia-Pacific Diabetes Drug Therapy Revenue by Application (2016-2026)
8.3 Asia-Pacific Diabetes Drug Therapy Market Size by Region
8.3.1 Asia-Pacific Diabetes Drug Therapy Revenue by Region (2016-2026)
8.3.2 China Diabetes Drug Therapy Market Size and Forecast (2016-2026)
8.3.3 Japan Diabetes Drug Therapy Market Size and Forecast (2016-2026)
8.3.4 South Korea Diabetes Drug Therapy Market Size and Forecast (2016-2026)
8.3.5 India Diabetes Drug Therapy Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Diabetes Drug Therapy Market Size and Forecast (2016-2026)
8.3.7 Australia Diabetes Drug Therapy Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Diabetes Drug Therapy Revenue by Type (2016-2026)
9.2 South America Diabetes Drug Therapy Revenue by Application (2016-2026)
9.3 South America Diabetes Drug Therapy Market Size by Country
9.3.1 South America Diabetes Drug Therapy Revenue by Country (2016-2026)
9.3.2 Brazil Diabetes Drug Therapy Market Size and Forecast (2016-2026)
9.3.3 Argentina Diabetes Drug Therapy Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Diabetes Drug Therapy Revenue by Type (2016-2026)
10.2 Middle East & Africa Diabetes Drug Therapy Revenue by Application (2016-2026)
10.3 Middle East & Africa Diabetes Drug Therapy Market Size by Country
10.3.1 Middle East & Africa Diabetes Drug Therapy Revenue by Country (2016-2026)
10.3.2 Turkey Diabetes Drug Therapy Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Diabetes Drug Therapy Market Size and Forecast (2016-2026)
10.3.4 UAE Diabetes Drug Therapy Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer

List of Tables
Table 1. Global Diabetes Drug Therapy Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Diabetes Drug Therapy Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Diabetes Drug Therapy Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Diabetes Drug Therapy Revenue (USD Million) by Region (2016-2021)
Table 5. Global Diabetes Drug Therapy Revenue Market Share by Region (2021-2026)
Table 6. Abbott Laboratories Corporate Information, Head Office, and Major Competitors
Table 7. Abbott Laboratories Major Business
Table 8. Abbott Laboratories Diabetes Drug Therapy Product and Solutions
Table 9. Abbott Laboratories Diabetes Drug Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Mannkind Corporation Corporate Information, Head Office, and Major Competitors
Table 11. Mannkind Corporation Major Business
Table 12. Mannkind Corporation Diabetes Drug Therapy Product and Solutions
Table 13. Mannkind Corporation Diabetes Drug Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Bristol Myers Squibb Corporate Information, Head Office, and Major Competitors
Table 15. Bristol Myers Squibb Major Business
Table 16. Bristol Myers Squibb Diabetes Drug Therapy Product and Solutions
Table 17. Bristol Myers Squibb Diabetes Drug Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Medtronic Corporate Information, Head Office, and Major Competitors
Table 19. Medtronic Major Business
Table 20. Medtronic Diabetes Drug Therapy Product and Solutions
Table 21. Medtronic Diabetes Drug Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. AstraZeneca Corporate Information, Head Office, and Major Competitors
Table 23. AstraZeneca Major Business
Table 24. AstraZeneca Diabetes Drug Therapy Product and Solutions
Table 25. AstraZeneca Diabetes Drug Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Eli Lilly and Company Corporate Information, Head Office, and Major Competitors
Table 27. Eli Lilly and Company Major Business
Table 28. Eli Lilly and Company Diabetes Drug Therapy Product and Solutions
Table 29. Eli Lilly and Company Diabetes Drug Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. GlaxoSmithKline Corporate Information, Head Office, and Major Competitors
Table 31. GlaxoSmithKline Major Business
Table 32. GlaxoSmithKline Diabetes Drug Therapy Product and Solutions
Table 33. GlaxoSmithKline Diabetes Drug Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. Sanofi Corporate Information, Head Office, and Major Competitors
Table 35. Sanofi Major Business
Table 36. Sanofi Diabetes Drug Therapy Product and Solutions
Table 37. Sanofi Diabetes Drug Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. Novo Nordisk Corporate Information, Head Office, and Major Competitors
Table 39. Novo Nordisk Major Business
Table 40. Novo Nordisk Diabetes Drug Therapy Product and Solutions
Table 41. Novo Nordisk Diabetes Drug Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. Novartis International AG Corporate Information, Head Office, and Major Competitors
Table 43. Novartis International AG Major Business
Table 44. Novartis International AG Diabetes Drug Therapy Product and Solutions
Table 45. Novartis International AG Diabetes Drug Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 46. Global Diabetes Drug Therapy Revenue (USD Million) by Players (2019-2021)
Table 47. Global Diabetes Drug Therapy Revenue Share by Players (2019-2021)
Table 48. Breakdown of Diabetes Drug Therapy by Company Type (Tier 1, Tier 2 and Tier 3)
Table 49. Diabetes Drug Therapy Players Head Office, Products and Services Provided
Table 50. Diabetes Drug Therapy Mergers & Acquisitions in the Past Five Years
Table 51. Diabetes Drug Therapy New Entrants and Expansion Plans
Table 52. Global Diabetes Drug Therapy Revenue (USD Million) by Type (2016-2021)
Table 53. Global Diabetes Drug Therapy Revenue Share by Type (2016-2021)
Table 54. Global Diabetes Drug Therapy Revenue Forecast by Type (2021-2026)
Table 55. Global Diabetes Drug Therapy Revenue by Application (2016-2021)
Table 56. Global Diabetes Drug Therapy Revenue Forecast by Application (2021-2026)
Table 57. North America Diabetes Drug Therapy Revenue by Type (2016-2021) & (USD Million)
Table 58. North America Diabetes Drug Therapy Revenue by Type (2021-2026) & (USD Million)
Table 59. North America Diabetes Drug Therapy Revenue by Application (2016-2021) & (USD Million)
Table 60. North America Diabetes Drug Therapy Revenue by Application (2021-2026) & (USD Million)
Table 61. North America Diabetes Drug Therapy Revenue by Country (2016-2021) & (USD Million)
Table 62. North America Diabetes Drug Therapy Revenue by Country (2021-2026) & (USD Million)
Table 63. Europe Diabetes Drug Therapy Revenue by Type (2016-2021) & (USD Million)
Table 64. Europe Diabetes Drug Therapy Revenue by Type (2021-2026) & (USD Million)
Table 65. Europe Diabetes Drug Therapy Revenue by Application (2016-2021) & (USD Million)
Table 66. Europe Diabetes Drug Therapy Revenue by Application (2021-2026) & (USD Million)
Table 67. Europe Diabetes Drug Therapy Revenue by Country (2016-2021) & (USD Million)
Table 68. Europe Diabetes Drug Therapy Revenue by Country (2021-2026) & (USD Million)
Table 69. Asia-Pacific Diabetes Drug Therapy Revenue by Type (2016-2021) & (USD Million)
Table 70. Asia-Pacific Diabetes Drug Therapy Revenue by Type (2021-2026) & (USD Million)
Table 71. Asia-Pacific Diabetes Drug Therapy Revenue by Application (2016-2021) & (USD Million)
Table 72. Asia-Pacific Diabetes Drug Therapy Revenue by Application (2021-2026) & (USD Million)
Table 73. Asia-Pacific Diabetes Drug Therapy Revenue by Region (2016-2021) & (USD Million)
Table 74. Asia-Pacific Diabetes Drug Therapy Revenue by Region (2021-2026) & (USD Million)
Table 75. South America Diabetes Drug Therapy Revenue by Type (2016-2021) & (USD Million)
Table 76. South America Diabetes Drug Therapy Revenue by Type (2021-2026) & (USD Million)
Table 77. South America Diabetes Drug Therapy Revenue by Application (2016-2021) & (USD Million)
Table 78. South America Diabetes Drug Therapy Revenue by Application (2021-2026) & (USD Million)
Table 79. South America Diabetes Drug Therapy Revenue by Country (2016-2021) & (USD Million)
Table 80. South America Diabetes Drug Therapy Revenue by Country (2021-2026) & (USD Million)
Table 81. Middle East & Africa Diabetes Drug Therapy Revenue by Type (2016-2021) & (USD Million)
Table 82. Middle East & Africa Diabetes Drug Therapy Revenue by Type (2021-2026) & (USD Million)
Table 83. Middle East & Africa Diabetes Drug Therapy Revenue by Application (2016-2021) & (USD Million)
Table 84. Middle East & Africa Diabetes Drug Therapy Revenue by Application (2021-2026) & (USD Million)
Table 85. Middle East & Africa Diabetes Drug Therapy Revenue by Country (2016-2021) & (USD Million)
Table 86. Middle East & Africa Diabetes Drug Therapy Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Diabetes Drug Therapy Picture
Figure 2. Global Diabetes Drug Therapy Revenue Market Share by Type in 2020
Figure 3. Oral
Figure 4. Subcutaneous
Figure 5. Intravenous
Figure 6. Diabetes Drug Therapy Revenue Market Share by Application in 2020
Figure 7. Online Pharmacies Picture
Figure 8. Hospital Pharmacies Picture
Figure 9. Retail Pharmacies Picture
Figure 10. Global Diabetes Drug Therapy Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 11. Global Diabetes Drug Therapy Revenue and Forecast (2016-2026) & (USD Million)
Figure 12. Global Diabetes Drug Therapy Revenue Market Share by Region (2016-2026)
Figure 13. Global Diabetes Drug Therapy Revenue Market Share by Region in 2020
Figure 14. North America Diabetes Drug Therapy Revenue (USD Million) and Growth Rate (2016-2026)
Figure 15. Europe Diabetes Drug Therapy Revenue (USD Million) and Growth Rate (2016-2026)
Figure 16. Asia-Pacific Diabetes Drug Therapy Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. South America Diabetes Drug Therapy Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. Diabetes Drug Therapy Market Drivers
Figure 19. Diabetes Drug Therapy Market Restraints
Figure 20. Diabetes Drug Therapy Market Trends
Figure 21. Abbott Laboratories Recent Developments and Future Plans
Figure 22. Mannkind Corporation Recent Developments and Future Plans
Figure 23. Bristol Myers Squibb Recent Developments and Future Plans
Figure 24. Medtronic Recent Developments and Future Plans
Figure 25. AstraZeneca Recent Developments and Future Plans
Figure 26. Eli Lilly and Company Recent Developments and Future Plans
Figure 27. GlaxoSmithKline Recent Developments and Future Plans
Figure 28. Sanofi Recent Developments and Future Plans
Figure 29. Novo Nordisk Recent Developments and Future Plans
Figure 30. Novartis International AG Recent Developments and Future Plans
Figure 32. Global Diabetes Drug Therapy Revenue Share by Players in 2020
Figure 33. Diabetes Drug Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 34. Global Top 3 Players Diabetes Drug Therapy Revenue Market Share in 2020
Figure 35. Global Top 10 Players Diabetes Drug Therapy Revenue Market Share in 2020
Figure 36. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 37. Global Diabetes Drug Therapy Revenue Share by Type in 2020
Figure 38. Global Diabetes Drug Therapy Market Share Forecast by Type (2021-2026)
Figure 39. Global Diabetes Drug Therapy Revenue Share by Application in 2020
Figure 40. Global Diabetes Drug Therapy Market Share Forecast by Application (2021-2026)
Figure 41. North America Diabetes Drug Therapy Sales Market Share by Type (2016-2026)
Figure 42. North America Diabetes Drug Therapy Sales Market Share by Application (2016-2026)
Figure 43. North America Diabetes Drug Therapy Revenue Market Share by Country (2016-2026)
Figure 44. United States Diabetes Drug Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 45. Canada Diabetes Drug Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 46. Mexico Diabetes Drug Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 47. Europe Diabetes Drug Therapy Sales Market Share by Type (2016-2026)
Figure 48. Europe Diabetes Drug Therapy Sales Market Share by Application (2016-2026)
Figure 49. Europe Diabetes Drug Therapy Revenue Market Share by Country (2016-2026)
Figure 50. Germany Diabetes Drug Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. France Diabetes Drug Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. United Kingdom Diabetes Drug Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. Russia Diabetes Drug Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. Italy Diabetes Drug Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. Asia-Pacific Diabetes Drug Therapy Sales Market Share by Type (2016-2026)
Figure 56. Asia-Pacific Diabetes Drug Therapy Sales Market Share by Application (2016-2026)
Figure 57. Asia-Pacific Diabetes Drug Therapy Revenue Market Share by Region (2016-2026)
Figure 58. China Diabetes Drug Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. Japan Diabetes Drug Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. South Korea Diabetes Drug Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. India Diabetes Drug Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. Southeast Asia Diabetes Drug Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Australia Diabetes Drug Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. South America Diabetes Drug Therapy Sales Market Share by Type (2016-2026)
Figure 65. South America Diabetes Drug Therapy Sales Market Share by Application (2016-2026)
Figure 66. South America Diabetes Drug Therapy Revenue Market Share by Country (2016-2026)
Figure 67. Brazil Diabetes Drug Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. Argentina Diabetes Drug Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. Middle East and Africa Diabetes Drug Therapy Sales Market Share by Type (2016-2026)
Figure 70. Middle East and Africa Diabetes Drug Therapy Sales Market Share by Application (2016-2026)
Figure 71. Middle East and Africa Diabetes Drug Therapy Revenue Market Share by Country (2016-2026)
Figure 72. Turkey Diabetes Drug Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. Saudi Arabia Diabetes Drug Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. UAE Diabetes Drug Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. Methodology
Figure 76. Research Process and Data Source

Global Diabetes Therapy and Drug Delivery Market Size, Status and Forecast 2021-2027
QYR2104Z1824 2021年4月 126Pages
QYResearch社発行の本調査資料では、糖尿病治療・ドラッグデリバリーのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（吸入可能型インスリン、経口型インスリン、インスリンパッチ、CGMシステム、人工膵臓）、用途別市場規模（診断/クリニック、I...

世界の次世代糖尿病治療＆ドラッグデリバリー市場規模・現状・予測（2021年-2027年）

Global Next Generation Diabetes Therapy and Drug Delivery Market Size, Status and Forecast 2021-2027
QYR2104Z4124 2021年4月 126Pages
QYResearch社発行の本調査資料では、次世代糖尿病治療＆ドラッグデリバリーのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（吸入インスリン、経口インスリン、インスリンパッチ、CGMシステム、人工膵臓）、用途別市場規模（診断/クリニック、IC...

Global Stem Cell Therapy for Diabetes and Related Conditions Market Size, Status and Forecast 2021-2027
QYR2104Z5440 2021年4月 97Pages
QYResearch社発行の本調査資料では、糖尿病及び関連疾患用幹細胞療法のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（単剤療法、併用療法）、用途別市場規模（1型糖尿病、2型糖尿病、糖尿病性足潰瘍、糖尿病性腎症、糖尿病性ニューロパチー）、主要...

世界のミリ波糖尿病治療装置市場 2021：企業別、地域別、種類・用途別

Global Millimeter Wave Diabetes Treatment Devices Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026
GIR-2104Z09401 2021年4月 105Pages
当調査資料では、ミリ波糖尿病治療装置のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。ミリ波糖尿病治療装置の種類別市場規模（50 GHz以下、50GHz以上）、用途別市場規模（1型糖尿病、2型糖尿病）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、...

世界の糖尿病治療製品市場 2021：企業別、地域別、種類・用途別

Global Diabetes Care Products Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026
GIR-2104Z04316 2021年4月 134Pages
当調査資料では、糖尿病治療製品のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。糖尿病治療製品の種類別市場規模（糖尿病検査製品、インスリンポンプ、糖尿病アクセサリー、糖尿病性フットケア、インスリン注射器）、用途別市場規模（医療、パーソナルケア）、地域別市...

世界の無針糖尿病管理市場 2021：企業別、地域別、種類・用途別

Global Needle Free Diabetes Management Market 2021 by Company, Regions, Type and Application, Forecast to 2026
GIR-2104Z09856 2021年4月 101Pages
当調査資料では、無針糖尿病管理のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。無針糖尿病管理の種類別市場規模（インスリン噴射式注射器、インスリンペン、インスリン吸入器、インスリンパッチ＆ポンプ）、用途別市場規模（病院、診療所、その他）、地域別市場規模（...

世界のミリ波治療（MWT）装置市場 2021：企業別、地域別、種類・用途別

Global Millimeter Wave Therapy (MWT) Devices Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026
GIR-2104Z09403 2021年4月 104Pages
当調査資料では、ミリ波治療（MWT）装置のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。ミリ波治療（MWT）装置の種類別市場規模（50 GHz以下、50GHz以上）、用途別市場規模（糖尿病治療、腫瘍＆癌治療）、地域別市場規模（北米、アメリカ、ヨーロッパ...

世界のミリ波治療機器市場 2021：企業別、地域別、種類・用途別

Global Millimeter Wave Therapy Instrument Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026
GIR-2104Z09404 2021年4月 104Pages
当調査資料では、ミリ波治療機器のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。ミリ波治療機器の種類別市場規模（50 GHz以下、50GHz以上）、用途別市場規模（糖尿病治療、腫瘍＆癌治療）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本...

世界の糖尿病用非インスリン療法市場 2021：企業別、地域別、種類・用途別

Global Non-Insulin Therapies for Diabetes Market 2021 by Company, Regions, Type and Application, Forecast to 2026
GIR-2104Z10042 2021年4月 121Pages
当調査資料では、糖尿病用非インスリン療法のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。糖尿病用非インスリン療法の種類別市場規模（α-グルコシダーゼ阻害剤、アミリンアゴニスト、ビグアニド、ジペプチジルペプチダーゼ-4（DPP4）阻害剤、グリニド/メグリ...

世界の埋め込み型薬剤注入ポンプ市場 2021：企業別、地域別、種類・用途別

Global Implantable Drug Infusion Pumps Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026
GIR-2104Z07461 2021年4月 107Pages
当調査資料では、埋め込み型薬剤注入ポンプのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。埋め込み型薬剤注入ポンプの種類別市場規模（患者管理型鎮痛（PCA）ポンプ、経腸ポンプ、インスリンポンプ、エラストマーポンプ、シリンジポンプ）、用途別市場規模（腫瘍学...

世界の糖尿病治療・ドラッグデリバリー市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Diabetes Therapy and Drug Delivery Market The global Diabetes Therapy and Drug Delivery market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high …
世界の次世代糖尿病治療＆ドラッグデリバリー市場規模・現状・予測（2021年-2027年） Next generation diabetic therapy and drug delivery systems are used to improve the adherence to insulin in diabetic patients to reduce the risk of complications related to sudden change in the blood sugar level. The market growth is attributed to the rise in the number of diabetic patients globally …
世界の糖尿病及び関連疾患用幹細胞療法市場規模・現状・予測（2021年-2027年） Diabetes is the metabolic disorder that is associated with the glucose level in the blood. It is mainly divided into two types, insulin-dependent diabetes mellitus or juvenile onset (type 1) and non-insulin-dependent diabetes mellitus, or adult-onset diabetes (type 2). NSI-566 is the stem cell thera…
世界の糖尿病用モニター市場規模・現状・予測（2021年-2027年） Diabetes mellitus is a chronic disease resulting from an inadequacy of insulin in the body. The condition causes either elevated blood-glucose concentrations, named as hyperglycaemia, or low glucose level known as hypoglycaemia. Monitoring glucose level is expected to prolong life expectancy as it e…
世界の糖尿病用モニター市場規模・現状・予測（2021年-2027年） Diabetes mellitus is a chronic disease resulting from an inadequacy of insulin in the body. The condition causes either elevated blood-glucose concentrations, named as hyperglycaemia, or low glucose level known as hypoglycaemia. Monitoring glucose level is expected to prolong life expectancy as it e…